Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Inogen Inc (NASDAQ: INGN) improved recently. INGN’s current Value Trend Rating is C and the prior Rating was D. Details […]
Stock Rating Downgrade In the last week the Value Trend Rating for Great Ajax Corp (NYSE: AJX) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Great Ajax Corp […]
Extremely important negative changes in investment behavior have recently occurred for Deluxe Corp (NYSE: DLX): the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, the stock fell […]
Cboe Global Markets Inc (BATS: CBOE) has reported E.P.S. of $1.87 for its fourth fiscal quarter (ending December 31) versus $1.99 for the same period a year ago — a decline of -6%. Relative to […]
Markel Corp (NYSE: MKL) stock closed at $2059.83 on 2/6/25 after a major increase of 10.7%. Moreover, this advance was accompanied by exceptionally high trading volume at 303% of normal. The stock has risen 14.2% […]
Liquidity Services Inc (NASDAQ: LQDT) has reported earnings for its first fiscal quarter (ending December 31) of $0.19 versus $0.06 for the same period a year ago — an increase of 217%. For the latest […]
Illumina Inc (NASDAQ: ILMN) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.17 versus a loss $-1.11 for the same period a year ago — a decline of -205%. E.P.S. were […]
For its fourth fiscal quarter (ending December 31), Eli Lilly and Co (NYSE: LLY) has reported a 101% increase in E.P.S. from $2.43 a year ago to $4.88 in the current quarter. For the latest […]
Deluxe Corp (NYSE: DLX) stock suffered a major decline of -11.3% on 2/6/25. The shares closed at $20.02. Moreover, this decline was accompanied by exceptionally high trading volume at 418% of normal. The stock has […]
On 2/6/25, Argan Inc (NYSE: AGX) stock enjoyed a major increase of 13.4%, closing at $162.12. Moreover, trading volume in this advance was exceptionally high at 219% of normal. The stock has risen 21.7% during […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research